Questcor Pharmacueticals (QCOR) Tops Q3 EPS by 20c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- Equities end higher as Anthropic's IPO filing buoys AI stocks
- Anthropic files for Nasdaq IPO as revenue jumps to $16.3 billion
- Meta reverses losses to rise as investors weigh $35 billion AI funding plan
- Post-election relief ahead for markets, says Morgan Stanley
- Musk says SpaceX raised $40 billion in debt, warns of neocloud collapse
Tweet
Share
E-mailGet Alerts QCOR Hot Sheet
Join SI Premium – FREE
Questcor Pharmacueticals (NASDAQ: QCOR) reported Q3 EPS of $0.97, $0.20 better than the analyst estimate of $0.77. Revenue for the quarter came in at $140.3 million versus the consensus estimate of $128.97 million.
For earnings history and earnings-related data on Questcor Pharmacueticals (QCOR) click here.
For earnings history and earnings-related data on Questcor Pharmacueticals (QCOR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JetBlue shares jump on Q3 results and 2027 outlook
- FirstSun Capital Bancorp (FSUN) Tops Q3 EPS by 6c
- Avidbank Holdings, Inc. (AVBH) Tops Q3 EPS by 7c
Create E-mail Alert Related Categories
Earnings, Hot EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
